The Rationale for CTO PCI: The Latest on Symptom Relief and Survival From Registries and Meta Analyses - Carlo Di Mario, MD

↳ This is a section part of Moment: CRT 2015 Coronary - Session 1: Like It or Not You Need to Know the Data

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$10.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

The Rationale for CTO PCI: The Latest on Symptom Relief and Survival From Registries and Meta Analyses presented by Carlo Di Mario, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$10.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows

Session Name: Session 1: Like It or Not You Need to Know the Data

Track: Coronary

Learning Objectives

Update in advances in CTO

Other Components in this Moment

Histopathologic Insights into Chronically Occluded Coronary Arteries – The Post-CABG vs Unbypassed CTO - Renu Virmani, MD

Native Coronary Patency after CABG Surgery: Clinical Implications - B. Strauss, MD, PhD

The Rationale for CTO PCI: The Latest on Symptom Relief and Survival From Registries and Meta Analyses - Carlo Di Mario, MD

Success and Safety of Contemporary CTO-PCI: The Latest From Recent Registries and Meta Analyses - D. Karmpaliotis , MD, PhD

Ongoing Randomized Trials: Where They Stand and What They Stand To Prove or Disprove - Gerald S. Werner, MD, PhD

The FDA’s View on CTO PCI: Why Everyday Devices Need CTO Specific Indications - Tara A Ryan, MD, MBA

Loading Simple Education